The RepliCel Life Sciences Inc brand, founded in 2000 (Canada), from 2214 competing brands. RepliCel Life Sciences Inc is owned by RepliCel Life Sciences Inc, listed on the stock exchange of Etats-Unis The ISIN, the company's International Securities Identification Number, is CA76027P4006. RepliCel Life Sciences Inc belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
RepliCel Life Sciences Inc
over 5 years*
USD 0.01